Tectonic Therapeutic (TECX) Competitors $21.67 +0.23 (+1.07%) As of 12:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TECX vs. EVO, ETNB, VERA, JANX, BHVN, ANIP, EWTX, MESO, TVTX, and CVACShould you be buying Tectonic Therapeutic stock or one of its competitors? The main competitors of Tectonic Therapeutic include Evotec (EVO), 89BIO (ETNB), Vera Therapeutics (VERA), Janux Therapeutics (JANX), Biohaven (BHVN), ANI Pharmaceuticals (ANIP), Edgewise Therapeutics (EWTX), Mesoblast (MESO), Travere Therapeutics (TVTX), and CureVac (CVAC). These companies are all part of the "pharmaceutical products" industry. Tectonic Therapeutic vs. Its Competitors Evotec 89BIO Vera Therapeutics Janux Therapeutics Biohaven ANI Pharmaceuticals Edgewise Therapeutics Mesoblast Travere Therapeutics CureVac Tectonic Therapeutic (NASDAQ:TECX) and Evotec (NASDAQ:EVO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation. Which has stronger valuation & earnings, TECX or EVO? Tectonic Therapeutic has higher earnings, but lower revenue than Evotec. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTectonic TherapeuticN/AN/A-$57.98M-$7.31-2.96Evotec$862.40M1.74-$212.18MN/AN/A Do institutionals & insiders hold more shares of TECX or EVO? 62.6% of Tectonic Therapeutic shares are owned by institutional investors. Comparatively, 5.8% of Evotec shares are owned by institutional investors. 9.2% of Tectonic Therapeutic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to TECX or EVO? In the previous week, Evotec had 1 more articles in the media than Tectonic Therapeutic. MarketBeat recorded 2 mentions for Evotec and 1 mentions for Tectonic Therapeutic. Tectonic Therapeutic's average media sentiment score of 1.87 beat Evotec's score of 0.94 indicating that Tectonic Therapeutic is being referred to more favorably in the media. Company Overall Sentiment Tectonic Therapeutic Very Positive Evotec Positive Do analysts rate TECX or EVO? Tectonic Therapeutic presently has a consensus price target of $83.60, suggesting a potential upside of 285.80%. Evotec has a consensus price target of $5.93, suggesting a potential upside of 40.60%. Given Tectonic Therapeutic's stronger consensus rating and higher possible upside, analysts plainly believe Tectonic Therapeutic is more favorable than Evotec.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.33Evotec 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Which has more risk & volatility, TECX or EVO? Tectonic Therapeutic has a beta of 3.17, meaning that its share price is 217% more volatile than the S&P 500. Comparatively, Evotec has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500. Is TECX or EVO more profitable? Tectonic Therapeutic has a net margin of 0.00% compared to Evotec's net margin of -26.34%. Evotec's return on equity of -21.51% beat Tectonic Therapeutic's return on equity.Company Net Margins Return on Equity Return on Assets Tectonic TherapeuticN/A -30.13% -27.52% Evotec -26.34%-21.51%-10.54% SummaryTectonic Therapeutic beats Evotec on 10 of the 14 factors compared between the two stocks. Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TECX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECX vs. The Competition Export to ExcelMetricTectonic TherapeuticMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$400.10M$2.92B$5.56B$9.26BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-2.9320.2728.5819.56Price / SalesN/A298.79434.47183.65Price / CashN/A43.1536.0257.93Price / Book2.277.668.165.58Net Income-$57.98M-$55.11M$3.24B$257.82M7 Day Performance0.55%0.03%-0.64%-0.39%1 Month Performance0.55%7.47%4.93%7.80%1 Year Performance26.06%-3.28%26.04%12.95% Tectonic Therapeutic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECXTectonic Therapeutic2.4872 of 5 stars$21.67+1.1%$83.60+285.8%+28.8%$400.10MN/A-2.93120Positive NewsEVOEvotec1.9816 of 5 stars$4.24+1.4%$5.93+40.0%-13.8%$1.51B$862.40M0.004,827ETNB89BIO1.8202 of 5 stars$10.10-1.1%$26.43+161.6%+16.8%$1.47BN/A-2.9940VERAVera Therapeutics4.2304 of 5 stars$23.09+0.5%$65.00+181.5%-36.9%$1.47BN/A-7.7040Positive NewsJANXJanux Therapeutics2.6849 of 5 stars$24.15+0.8%$95.25+294.4%-40.7%$1.43B$9.34M-17.7630BHVNBiohaven3.3508 of 5 stars$13.96+1.2%$58.46+318.8%-65.5%$1.43BN/A-1.49239Trending NewsANIPANI Pharmaceuticals3.7316 of 5 stars$65.17+0.4%$80.13+22.9%+1.2%$1.41B$674.07M-51.31600News CoverageAnalyst RevisionEWTXEdgewise Therapeutics1.4581 of 5 stars$12.92+2.5%$40.00+209.6%-41.5%$1.36BN/A-8.3460MESOMesoblast2.1929 of 5 stars$10.59+0.5%$18.00+70.1%+43.3%$1.35B$5.90M0.0080Gap UpTVTXTravere Therapeutics3.7915 of 5 stars$15.02+2.8%$32.14+114.0%+67.0%$1.33B$233.18M-5.35460Positive NewsAnalyst RevisionCVACCureVac4.7219 of 5 stars$5.43+0.3%$6.83+26.0%+50.3%$1.22B$579.18M5.90880Positive News Related Companies and Tools Related Companies Evotec Competitors 89BIO Competitors Vera Therapeutics Competitors Janux Therapeutics Competitors Biohaven Competitors ANI Pharmaceuticals Competitors Edgewise Therapeutics Competitors Mesoblast Competitors Travere Therapeutics Competitors CureVac Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
